Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TLRY — Tilray Brands, Inc.

CIK 1423053 MIAMI, FL
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$3,897,979
+$3,807,995 QoQ
Shares Held
868,147
+6142.1% QoQ
Ownership
0.637%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 235 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Derivatives in TLRY

reported options exposure · as of Jun 30, 2026
CallValue
$3,980,385
CallShares
886,500
PutValue
$3,551,185
PutShares
790,910

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. TLRY ranks #20 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in TLRY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,551,185 790,910
2026-06-30 $3,897,979 868,147
2026-06-30 $3,980,385 886,500
2026-03-31 $89,984 13,908
2026-03-31 $6,459,259 998,340
2026-03-31 $3,945,017 609,740
2025-12-31 $11,729,789 1,298,980
2025-12-31 $14,293,045 1,582,840
2025-12-31 $1,377,878 152,589
2025-09-30 $11,764,865 6,800,500
2025-09-30 $3,197,465 1,848,246
2025-09-30 $3,787,662 2,189,400
2025-06-30 $2,277,122 5,553,958
2025-06-30 $691,383 1,686,300
2025-06-30 $898,433 2,191,300
2025-03-31 $207,342 314,156
2025-03-31 $1,978,680 2,998,000
2025-03-31 $1,474,704 2,234,400
2024-12-31 $3,311,434 2,489,800
2024-12-31 $3,632,058 2,730,871
2024-12-31 $4,418,659 3,322,300
2024-09-30 $2,698,432 1,533,200
2024-09-30 $3,258,420 1,851,375
2024-09-30 $4,284,368 2,434,300
2024-06-30 $1,235,206 744,100
2024-06-30 $2,533,990 1,526,500
2024-03-31 $2,958,566 1,197,800
2024-03-31 $6,735,690 2,727,000
2024-03-31 $5,904,332 2,390,418
2023-12-31 $10,292,249 4,474,891
2023-12-31 $2,218,350 964,500
2023-12-31 $1,882,372 818,423
2023-09-30 $2,018,863 844,713
2023-09-30 $9,492,090 3,971,586
2023-09-30 $3,450,653 1,443,788
2023-06-30 $5,148,227 3,300,146
2023-06-30 $447,629 286,942
2023-06-30 $1,640,719 1,051,743
2023-03-31 $7,115,372 2,812,400
2023-03-31 $70,556 27,888
2023-03-31 $3,309,240 1,308,000
2022-12-31 $5,020,277 1,866,274
2022-12-31 $666,608 247,810
2022-12-31 $11,650,408 4,331,007
2022-09-30 $11,425,900 4,154,873
2022-09-30 $3,395,702 1,234,801
2022-09-30 $6,787,437 2,468,159
2022-06-30 $5,337,930 1,710,875
2022-06-30 $11,856,296 3,800,095
2022-06-30 $7,592,392 2,433,459